Tissue Engineering and Regeneration: Technologies and Global Markets

Report Highlights

The global market for tissue engineering and regeneration is expected to reach $60.8 billion by 2021 from $13.6 billion in 2016, rising at a compound annual growth rate (CAGR) of 34.9% from 2016 through 2021.

Report Includes

• An overview of the global market for tissue engineering and regeneration, and related technologies.
• Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
• Information on the specific drivers, trends, and challenges for different segments of the market.
• Valuable insight into future trends, details on products, and information on therapies available in the field of tissue engineering.
• Analysis of the competitive environments, including new and potential markets for novel therapies and treatments.  
• Profiles of major players in the industry.

Report Scope

This report covers all the revenues earned by the regeneration therapies. These therapies are extensively used to replace and regenerate the cells, genes and tissues in a patient’s body. The report considers revenue generated by the products, as well as services in the regenerative medicine market. The services include the tools, along with the cell and gene bank charges, where the cells and tissues are stored and treated properly pre- and post-experimentation and treatment. The report also covers the revenues earned by small molecules and biologics (drugs) that speed up the regeneration process. Other drug therapy revenues (e.g., painkillers, analgesics) that can be used along with regenerative therapy are not included in the report, as they do not contribute to cell or tissue regeneration. The report covers all the existing applications of the regenerative medicine therapy.

The global tissue engineering and regeneration market is primarily segmented by components, materials, applications and region. The tissue engineering and regenerative medicine component market is categorized into therapeutic products, tools, banks and services. These therapeutic products are further segmented into cell therapy, gene therapy, tissue engineering, and small molecules and biologics based on product type.

The therapeutic products are also categorized into synthetic materials, biologically derived materials, genetically engineered materials, and small molecules and biologics based on material. The report includes key technologies involved in regenerative medicine therapy. The study analyzes the clinical trials and patents conducted in respective regions. The report provides an in-depth analysis of the key companies operating in the global tissue engineering and regeneration market.

The market is segmented by region as North America, Europe, Asia-Pacific and ROW. Companies profiled in this report include Advanced Cell Technology, Arteriocyte, Athersys, Bioheart, BioMimetic Therapeutics, BioTissue Technologies, CeraPedics, Cook Biotech, CryoLife, Cytograft Tissue Engineering, Cytomedix, Cytori Therapeutics, Genzyme/Sanofi, Integra LifeSciences, International Stem Cell, LifeCell/Kinetic Concepts and Mesoblast.

Analyst Credentials

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, the life sciences market, and in the chemical domain. She has frequently delivered research services that contain strategic recommendations and top business strategies to help market players make strategic decision. She holds an MBA in Marketing.